These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2506695)

  • 61. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. II. Investigation into the mechanism of lysis.
    Urbaniak SJ
    Br J Haematol; 1979 Jun; 42(2):315-25. PubMed ID: 111699
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Estimation of the degree of opsonization of homologous erythrocytes by IgG for intravenous and intramuscular use.
    Jungi TW; Barandun S
    Vox Sang; 1985; 49(1):9-19. PubMed ID: 4013145
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
    Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
    Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Critical evaluation of the ADCC test.
    Brojer E; Górska B
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):231-8. PubMed ID: 3098206
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IgG subclass distribution of anti-Rh, anti-Kell and anti-Duffy antibodies measured by sensitive haemagglutination assays.
    Michaelsen TE; Kornstad L
    Clin Exp Immunol; 1987 Mar; 67(3):637-45. PubMed ID: 3111763
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Human mononuclear cell antibody-dependent cell-mediated cytotoxicity toward red blood cells of various Rh genotypes.
    Jabs AD; Okubo K; Okubo K; Yokoyama MM
    Kurume Med J; 1982; 29(4):163-72. PubMed ID: 6821118
    [No Abstract]   [Full Text] [Related]  

  • 67. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function.
    Armstrong-Fisher SS; Carter MC; Downing I; Fraser RH; Inglis GE; Allan EK; Mackie A; Prowse CV; Templeton JG; Thorpe SJ; Urbaniak SJ
    Transfusion; 1999 Sep; 39(9):1005-12. PubMed ID: 10533828
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IgG3 anti-Kell allotypic variation results in differential antigen binding and phagocytosis.
    Cen SY; Holton MB; Binnington B; Denomme GA; Howie HL; Lebedev JN; Zimring JC; Branch DR
    Transfusion; 2020 Apr; 60(4):688-693. PubMed ID: 31930726
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radio-immunoassay of the functional activity of anti-D (Rh) preparations using a human monoclonal 125I-labelled anti-D.
    Hughes-Jones NC; Dawes B; Gorick BD; Melamed MD; Pepper R; Thompson KM
    Vox Sang; 1987; 53(3):175-80. PubMed ID: 3120414
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents.
    Montano RF; Penichet ML; Blackall DP; Morrison SL; Chintalacharuvu KR
    J Immunol Methods; 2009 Jan; 340(1):1-10. PubMed ID: 18848836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
    Braster R; Grewal S; Visser R; Einarsdottir HK; van Egmond M; Vidarsson G; Bögels M
    PLoS One; 2017; 12(5):e0177736. PubMed ID: 28542406
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human monoclonal anti-D-induced clearance of human D-positive red cells in a chimpanzee model.
    Blancher A; Socha WW; Roubinet F; Rowe AW; Broly H; Byrne P; Holuigue M; Bouzidi A; Huart JJ; Ruffié J
    Vox Sang; 1993; 65(1):47-54. PubMed ID: 8362514
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Fc receptors for IgG1 and IgG3 on human mononuclear cells--an evaluation with known levels of erythrocyte-bound IgG.
    Zupańska B; Thomson EE; Merry AH
    Vox Sang; 1986; 50(2):97-103. PubMed ID: 3515762
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn.
    Pollock JM; Bowman JM
    Vox Sang; 1990; 59(3):176-9. PubMed ID: 2124753
    [TBL] [Abstract][Full Text] [Related]  

  • 75. IgG anti-D MAbs in tests by flow cytometry.
    Roubinet F; Blancher A
    Transfus Clin Biol; 1996; 3(6):419-23. PubMed ID: 9018801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Evaluation of monoclonal anti-Rh antibodies as reagents for blood grouping and for the identification of red cell membrane components associated with Rh antigen activity.
    Moore S; Green C; McGowan A
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):141-4. PubMed ID: 3145542
    [No Abstract]   [Full Text] [Related]  

  • 77. The clearance kinetics of autologous RhD-positive erythrocytes coated ex vivo with novel recombinant and monoclonal anti-D antibodies.
    Chapman GE; Ballinger JR; Norton MJ; Parry-Jones DR; Beharry NA; Cousins C; Dash CH; Peters AM
    Clin Exp Immunol; 2007 Oct; 150(1):30-41. PubMed ID: 17680827
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Idiotypic specificities of anti-Rhesus (D) monoclonal antibodies.
    Lambin P; Rouger P; Herance N; Debbia M; Fine JM; Salmon C
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):245-8. PubMed ID: 3145552
    [No Abstract]   [Full Text] [Related]  

  • 79. Activation of monocytes for the immune clearance of red cells in beta zero-thalassaemia/HbE.
    Wanachiwanawin W; Siripanyaphinyo U; Fucharoen S; Wasi P; Mawas F; Wiener E; Wickramasinghe SN
    Br J Haematol; 1993 Dec; 85(4):773-7. PubMed ID: 7918042
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.
    Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ
    Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.